• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by Astrana Health Inc.

    4/17/25 9:35:28 AM ET
    $ASTH
    Professional Services
    Consumer Discretionary
    Get the next $ASTH alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 6)


    Astrana Health, Inc.

    (Name of Issuer)


    Common Stock

    (Title of Class of Securities)


    03763A207

    (CUSIP Number)


    03/31/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    03763A207


    1Names of Reporting Persons

    BlackRock, Inc.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    6,185,606.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    6,234,446.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    6,234,446.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    12.4 %
    12Type of Reporting Person (See Instructions)

    HC


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    Astrana Health, Inc.
    (b)Address of issuer's principal executive offices:

    1668 S. GARFIELD AVENUE, 2ND FLOOR ALHAMBRA CA 91801
    Item 2. 
    (a)Name of person filing:

    BlackRock, Inc. In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by certain business units (collectively, the "Reporting Business Units") of BlackRock, Inc. and its subsidiaries and affiliates. It does not include securities, if any, beneficially owned by other business units whose beneficial ownership of securities are disaggregated from that of the Reporting Business Units in accordance with such release.
    (b)Address or principal business office or, if none, residence:

    BlackRock, Inc., 50 Hudson Yards New York, NY 10001
    (c)Citizenship:

    See Item 4 of Cover Page
    (d)Title of class of securities:

    Common Stock
    (e)CUSIP No.:

    03763A207
    Item 4.Ownership
    (a)Amount beneficially owned:

    6234446
    (b)Percent of class:

    12.4  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    6185606

     (ii) Shared power to vote or to direct the vote:

    0

     (iii) Sole power to dispose or to direct the disposition of:

    6234446

     (iv) Shared power to dispose or to direct the disposition of:

    0

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    The interest of 1 such person, iShares Core S&P Small-Cap ETF, in the common stock of Astrana Health, Inc. is more than five percent of the total outstanding common stock.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.


    See Exhibit 99
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    BlackRock, Inc.
     
    Signature:Spencer Fleming
    Name/Title:Managing Director
    Date:04/17/2025
    Exhibit Information

    Exhibit 24: Power of Attorney Exhibit 99: Item 7

    Get the next $ASTH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ASTH

    DatePrice TargetRatingAnalyst
    4/1/2025$36.00Equal Weight
    Barclays
    10/14/2024$66.00Buy
    TD Cowen
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    7/11/2024$44.00 → $50.00Hold → Buy
    Truist
    5/30/2024$54.00Outperform
    Robert W. Baird
    More analyst ratings

    $ASTH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Astrana Health, Inc. Reports First Quarter 2025 Results

      Company to Host Conference Call on Thursday, May 8, 2025, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., May 8, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the first quarter ended March 31, 2025. "Astrana's strong start to the year reflects the continued momentum behind our mis

      5/8/25 4:05:00 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • Astrana Health, Inc. to Participate in Upcoming Investor Conference

      ALHAMBRA, Calif., April 24, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that Brandon Sim, President and CEO, and Chan Basho, CFO and COO, are participating in the BofA Securities 2025 Health Care Conference, being held in Las Vegas, on Tuesday, May 13, 2025, including a fireside chat at 3:00pm PT. The webcast link will be available in the "IR Calendar" section of the Company's website: https://ir.astranahealth.com/news-events/ir-c

      4/24/25 8:30:00 AM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • Astrana Health, Inc. Schedules 2025 First Quarter Financial Results Release and Conference Call

      ALHAMBRA, Calif., April 15, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the first quarter ended March 31, 2025, after the close of the stock market on Thursday, May 8, 2025. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.

      4/15/25 4:05:00 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary

    $ASTH
    SEC Filings

    See more
    • Astrana Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Astrana Health, Inc. (0001083446) (Filer)

      5/13/25 4:15:50 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • SEC Form 10-Q filed by Astrana Health Inc.

      10-Q - Astrana Health, Inc. (0001083446) (Filer)

      5/9/25 5:02:17 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • Astrana Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Astrana Health, Inc. (0001083446) (Filer)

      5/8/25 4:15:57 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary

    $ASTH
    Financials

    Live finance-specific insights

    See more
    • Astrana Health, Inc. Reports First Quarter 2025 Results

      Company to Host Conference Call on Thursday, May 8, 2025, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., May 8, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the first quarter ended March 31, 2025. "Astrana's strong start to the year reflects the continued momentum behind our mis

      5/8/25 4:05:00 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • Astrana Health, Inc. Schedules 2025 First Quarter Financial Results Release and Conference Call

      ALHAMBRA, Calif., April 15, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the first quarter ended March 31, 2025, after the close of the stock market on Thursday, May 8, 2025. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.

      4/15/25 4:05:00 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • Astrana Health, Inc. Reports Fourth Quarter and Year-End 2024 Results

      Company to Host Conference Call on Thursday, February 27, 2025, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., Feb. 27, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the fourth quarter and year ended December 31, 2024. "Astrana Health's strong performance in 2024 highlights the s

      2/27/25 4:27:00 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary

    $ASTH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • COO and CFO Basho Chandan covered exercise/tax liability with 10,035 shares, decreasing direct ownership by 5% to 178,640 units (SEC Form 4)

      4 - Astrana Health, Inc. (0001083446) (Issuer)

      5/19/25 6:12:01 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • Chief Medical Officer Kumar Dinesh M. covered exercise/tax liability with 828 shares, decreasing direct ownership by 0.36% to 227,298 units (SEC Form 4)

      4 - Astrana Health, Inc. (0001083446) (Issuer)

      4/30/25 8:44:02 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • COO and CFO Basho Chandan covered exercise/tax liability with 2,683 shares, decreasing direct ownership by 1% to 188,675 units (SEC Form 4)

      4 - Astrana Health, Inc. (0001083446) (Issuer)

      4/16/25 4:15:20 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary

    $ASTH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Barclays initiated coverage on Astrana Health with a new price target

      Barclays initiated coverage of Astrana Health with a rating of Equal Weight and set a new price target of $36.00

      4/1/25 7:41:49 AM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • TD Cowen initiated coverage on Astrana Health with a new price target

      TD Cowen initiated coverage of Astrana Health with a rating of Buy and set a new price target of $66.00

      10/14/24 7:24:49 AM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • KeyBanc Capital Markets initiated coverage on Astrana Health

      KeyBanc Capital Markets initiated coverage of Astrana Health with a rating of Sector Weight

      10/11/24 7:36:28 AM ET
      $ASTH
      Professional Services
      Consumer Discretionary